| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | ABT-888 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Erlotinib | GDSC1000 | pan-cancer | AAC | 0.031 | 0.5 |
| mRNA | Irinotecan | CCLE | pan-cancer | AAC | -0.033 | 0.5 |
| mRNA | Nilotinib | FIMM | pan-cancer | AAC | -0.11 | 0.5 |
| mRNA | carboplatin:UNC0638 (2:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | Cetuximab | GDSC1000 | pan-cancer | AAC | -0.02 | 0.5 |
| mRNA | SGX-523 | CTRPv2 | pan-cancer | AAC | 0.023 | 0.5 |
| mRNA | 5-FU | CTRPv2 | pan-cancer | AAC | 0.02 | 0.5 |
| mRNA | birinapant | CTRPv2 | pan-cancer | AAC | -0.022 | 0.5 |
| mRNA | BRD-A05715709 | CTRPv2 | pan-cancer | AAC | -0.033 | 0.5 |